UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.732

Sortiert nach

Development of innate and adaptive immunity to RSV in young children

Cellular immunology, 2024-05, Vol.399-400, p.104824-104824, Article 104824

2024

Link zum Volltext

Verfügbarkeit prüfen

Prefusion F Protein–Based Respiratory Syncytial Virus Immunization in Pregnancy

The New England journal of medicine, 2022-04, Vol.386 (17), p.1615-1626

2022

Link zum Volltext

Verfügbarkeit prüfen

The race to make vaccines for a dangerous respiratory virus

Nature (London), 2021-12, Vol.600 (7889), p.379-380

Powell, Kendall

2021

Link zum Volltext

Verfügbarkeit prüfen

Viral N 6 -methyladenosine upregulates replication and pathogenesis of human respiratory syncytial virus

Nature communications, 2019-10, Vol.10 (1), p.4595-18

2019

Link zum Volltext

Verfügbarkeit prüfen

An Adjuvanted, Postfusion F Protein–Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults

The Journal of infectious diseases, 2017-12, Vol.216 (11), p.1362-1370

2017

Link zum Volltext

Verfügbarkeit prüfen

Investigational RSV Vaccine Given During Pregnancy Protects Newborns

JAMA : the journal of the American Medical Association, 2022-12, Vol.328 (22), p.2201

Larkin, Howard

2022

Link zum Volltext

Verfügbarkeit prüfen

Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection

Antimicrobial agents and chemotherapy, 2016-01, Vol.60 (1), p.6-13

2016

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model

Nature communications, 2018-05, Vol.9 (1), p.1904-10, Article 1904

2018

Link zum Volltext

Verfügbarkeit prüfen

Vaccination against respiratory syncytial virus in pregnancy: a suitable tool to combat global infant morbidity and mortality?

The Lancet infectious diseases, 2016-08, Vol.16 (8), p.e153-e163

2016

Link zum Volltext

Verfügbarkeit prüfen

Safety and Immunogenicity of Bivalent RSVpreF Vaccine Coadministered With Seasonal Inactivated Influenza Vaccine in Older Adults

Clinical infectious diseases, 2024-05, Vol.78 (5), p.1360-1368

2024

Link zum Volltext

Verfügbarkeit prüfen

A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant

The Journal of infectious diseases, 2017-01, Vol.215 (1), p.24-33

2017

Link zum Volltext

Verfügbarkeit prüfen

Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children

The Journal of infectious diseases, 2020-02, Vol.221 (4), p.534-543

2020

Link zum Volltext

Verfügbarkeit prüfen

Passive and active immunization against respiratory syncytial virus for the young and old

Expert review of vaccines, 2017-07, Vol.16 (7), p.737-749

2017

Link zum Volltext

Verfügbarkeit prüfen

The CD4 T cell response to respiratory syncytial virus infection

Immunologic research, 2014-08, Vol.59 (1-3), p.109-117

2014

Link zum Volltext

Verfügbarkeit prüfen

Estimating the impact of multiple immunization products on medically-attended respiratory syncytial virus (RSV) infections in infants

Vaccine, 2020-01, Vol.38 (2), p.251-257

2020

Link zum Volltext

Verfügbarkeit prüfen

Equivalent immunogenicity across three RSVpreF vaccine lots in healthy adults 18–49 years of age: Results of a randomized phase 3 study

Vaccine, 2024-05, Vol.42 (13), p.3172-3179

2024

Link zum Volltext

Verfügbarkeit prüfen

Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses

Immunity (Cambridge, Mass.), 2021-04, Vol.54 (4), p.769-780.e6

2021

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age

PloS one, 2013-10, Vol.8 (10), p.e77104

2013

Link zum Volltext

Verfügbarkeit prüfen

Safety and Immunogenicity of 3 Formulations of an Investigational Respiratory Syncytial Virus Vaccine in Nonpregnant Women: Results From 2 Phase 2 Trials

The Journal of infectious diseases, 2018-04, Vol.217 (10), p.1616-1625

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical and epidemiologic features of respiratory syncytial virus

Current topics in microbiology and immunology, 2013, Vol.372, p.39

2013

Link zum Volltext

Verfügbarkeit prüfen

Dose Selection for an Adjuvanted Respiratory Syncytial Virus F Protein Vaccine for Older Adults Based on Humoral and Cellular Immune Responses

Clinical and vaccine immunology, 2017-09, Vol.24 (9)

2017

Link zum Volltext

Verfügbarkeit prüfen

Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection

PLoS medicine, 2013-11, Vol.10 (11), p.e1001549-e1001549

2013

Link zum Volltext

Verfügbarkeit prüfen

A Novel Live Attenuated Respiratory Syncytial Virus Vaccine Candidate with Mutations in the L Protein SAM Binding Site and the G Protein Cleavage Site Is Protective in Cotton Rats and a Rhesus Macaque

Journal of virology, 2021-01, Vol.95 (3)

2021

Link zum Volltext

Verfügbarkeit prüfen

Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy?

Current opinion in infectious diseases, 2015-06, Vol.28 (3), p.221-224

Munoz, Flor M

2015

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial

The Lancet infectious diseases, 2015-12, Vol.15 (12), p.1398-1408

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.732

Suche als RSS-Feed

Aktive Filter

ThemaMice

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.628)
Mit Volltextzugriff
(1.483)

Publikationsform

Sprache

10 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.566)
Humans
(1.542)
Life Sciences & Biomedicine
(1.507)
Male
(1.395)
Respiratory Syncytial Virus
(1.077)
Infant
(993)
Immunology
(981)
Infectious Diseases
(827)
Child, Preschool
(625)
Biological And Medical Sciences
(606)
Medical Sciences
(538)
Infant, Newborn
(511)
Microbiology
(456)
Pediatrics
(455)
Respiratory Syncytial Virus Infections - Immunology
(437)
Child
(427)
Adult
(394)
Viruses
(390)
Respiratory Syncytial Viruses - Immunology
(379)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Development of innate and adaptive immunity to RSV in young children

Prefusion F Protein–Based Respiratory Syncytial Virus Immunization in Pregnancy

The race to make vaccines for a dangerous respiratory virus

Viral N 6 -methyladenosine upregulates replication and pathogenesis of human respiratory syncytial virus

An Adjuvanted, Postfusion F Protein–Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults

Investigational RSV Vaccine Given During Pregnancy Protects Newborns

Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection

Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model

Vaccination against respiratory syncytial virus in pregnancy: a suitable tool to combat global infant morbidity and mortality?

Safety and Immunogenicity of Bivalent RSVpreF Vaccine Coadministered With Seasonal Inactivated Influenza Vaccine in Older Adults

A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant

Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children

Passive and active immunization against respiratory syncytial virus for the young and old

The CD4 T cell response to respiratory syncytial virus infection

Estimating the impact of multiple immunization products on medically-attended respiratory syncytial virus (RSV) infections in infants

Equivalent immunogenicity across three RSVpreF vaccine lots in healthy adults 18–49 years of age: Results of a randomized phase 3 study

Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses

Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age

Safety and Immunogenicity of 3 Formulations of an Investigational Respiratory Syncytial Virus Vaccine in Nonpregnant Women: Results From 2 Phase 2 Trials

Clinical and epidemiologic features of respiratory syncytial virus

Dose Selection for an Adjuvanted Respiratory Syncytial Virus F Protein Vaccine for Older Adults Based on Humoral and Cellular Immune Responses

Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection

A Novel Live Attenuated Respiratory Syncytial Virus Vaccine Candidate with Mutations in the L Protein SAM Binding Site and the G Protein Cleavage Site Is Protective in Cotton Rats and a Rhesus Macaque

Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy?

Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial

Aktive Filter

Suchergebnisse filtern